In this commentary, Robert Rosenson, MD, explains that PCSK9 inhibitors may be a useful alternative therapy in lowering LDL cholesterol in individuals who are unable to tolerate statins at the doses...
In this commentary, Jessica Tomaszewski, MD, discusses a Top Paper about the trend in US outpatient antibiotic prescriptions and what that means for practice.
In this commentary, Jessica Tomaszewski, MD, discusses a Top Paper about the trend in US outpatient antibiotic prescriptions and what that means for practice.
In this commentary, Jessica Tomaszewski, MD, discusses a Top Paper about the trend in US outpatient antibiotic prescriptions and what that means for practice.
In this commentary, M. Chiara Manzini, PhD, provides an overview of her research on gender bias in autism and why being aware of such bias is important for neurologists.
In this commentary, Vikas Majithia, MD, MPH, explains results of the PEXIVAS study and how they will impact the way rheumatologists treat patients with anti-neutrophil cytoplasm antibody-associated...
In this commentary, Vikas Majithia, MD, MPH, explains results of the PEXIVAS study and how they will impact the way rheumatologists treat patients with anti-neutrophil cytoplasm antibody-associated...
